全文获取类型
收费全文 | 4891篇 |
免费 | 318篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 211篇 |
妇产科学 | 69篇 |
基础医学 | 578篇 |
口腔科学 | 84篇 |
临床医学 | 354篇 |
内科学 | 1067篇 |
皮肤病学 | 71篇 |
神经病学 | 371篇 |
特种医学 | 129篇 |
外科学 | 535篇 |
综合类 | 122篇 |
一般理论 | 2篇 |
预防医学 | 256篇 |
眼科学 | 339篇 |
药学 | 495篇 |
1篇 | |
中国医学 | 42篇 |
肿瘤学 | 416篇 |
出版年
2023年 | 48篇 |
2022年 | 105篇 |
2021年 | 168篇 |
2020年 | 103篇 |
2019年 | 146篇 |
2018年 | 179篇 |
2017年 | 129篇 |
2016年 | 178篇 |
2015年 | 172篇 |
2014年 | 228篇 |
2013年 | 301篇 |
2012年 | 413篇 |
2011年 | 365篇 |
2010年 | 188篇 |
2009年 | 171篇 |
2008年 | 266篇 |
2007年 | 308篇 |
2006年 | 313篇 |
2005年 | 209篇 |
2004年 | 206篇 |
2003年 | 177篇 |
2002年 | 143篇 |
2001年 | 66篇 |
2000年 | 62篇 |
1999年 | 61篇 |
1998年 | 22篇 |
1997年 | 18篇 |
1996年 | 13篇 |
1995年 | 15篇 |
1994年 | 10篇 |
1993年 | 14篇 |
1992年 | 41篇 |
1991年 | 37篇 |
1990年 | 35篇 |
1989年 | 38篇 |
1988年 | 28篇 |
1987年 | 23篇 |
1986年 | 17篇 |
1985年 | 19篇 |
1984年 | 24篇 |
1983年 | 17篇 |
1982年 | 9篇 |
1980年 | 13篇 |
1979年 | 8篇 |
1977年 | 8篇 |
1975年 | 9篇 |
1974年 | 16篇 |
1973年 | 14篇 |
1971年 | 8篇 |
1969年 | 7篇 |
排序方式: 共有5228条查询结果,搜索用时 24 毫秒
51.
52.
53.
Thomas?M.?Todoran Jay?Giri Geoffrey?D.?Barnes Rachel?P.?Rosovsky Yuchiao?Chang Michael?R.?Jaff Kenneth?Rosenfield Christopher?Kabrhel 《Journal of thrombosis and thrombolysis》2018,46(1):39-49
There is a paucity of robust clinical trial data to guide the treatment of acute pulmonary embolism (PE) thus the clinical guidelines rely heavily on expert opinion. Pulmonary Embolism Response Teams (PERT) have been developed to streamline the care of patients with acute PE. We conducted a survey among 100 experts in the field of PE during the second annual meeting of the PERT Consortium. Respondents were queried with respect to their demographic information, clinical practice questions and clinical vignettes. Clinical practice questions were focused questions about the risk stratification and treatment of patients with acute submassive PE, anticoagulation strategies for patients receiving thrombolysis and the use of inferior vena cava filters. Clinical vignettes were designed to assess participants’ preferred choice of treatment for a variety of commonly encountered clinical scenarios. Among physicians affiliated with a PERT, there is overall agreement with regards to the criteria used for risk classification of patients with PE and its application to patients in the provided clinical vignettes. In contrast, there is substantial variability in the treatment strategies of patients presenting with commonly encountered clinical scenarios. The results of this survey highlight the need for more clinical trial data along with accepted algorithms for treatment of acute PE. In the absence of this, PERTs can facilitate multidisciplinary discussions in order to standardize treatment and provide evidence-based therapies to patients with acute PE. 相似文献
54.
55.
56.
57.
58.
ObjectiveTo evaluate the hypoglycemic and anti-obesity activities of of Murraya koenigii leaves.MethodThe study was performed in high fatty diet induced obesity rats. After 15 days baseline period the treatments animals were received ethanolic extract of Murraya koenigii leaves (300 and 500 mg/kg) in high fatty diet rats. All the treatments were given for one month. On 30th day all the fasted animals received an intraperitoneal injection of glucose (1 g/kg) for glucose tolerance test. At the end of study body weight, total cholesterol, triglycerides, and blood glucose level were measured.ResultsThe results demonstrate clearly that repeated oral administration of Murraya koenigii leaves evoked a potent anti-hyperglycaemic activity in high fat diet obese rats. Postprandial hyperglycaemic peaks were significantly lower in plant-treated experimental groups. In other hand, high fatty diet group increased the both total cholesterol and triglycerides levels as compared to control group. While administration of Murraya koenigii leaves significantly decreased in both cholesterol as well as triglycerides.ConclusionsWe can conclude that Murraya koenigii leaves evokes potent anti-hyperglycaemic and anti-obesity effects. This fact could support their use by the diabetes patient for controlling body weight as well as maintains the glycemic level. 相似文献
59.
Emanuele Chisari Steven Yacovelli Karan Goswami Noam Shohat Paul Woloszyn Javad Parvizi 《The Journal of arthroplasty》2021,36(8):2942-2945.e1
BackgroundA leukocyte esterase (LE) test is inexpensive and provides real-time information about patients suspected of periprosthetic joint infections (PJIs). The 2018 International Consensus Meeting (ICM) recommends it as a diagnostic tool with a 2+ cutoff. There is still a lack of data revealing LE utility versus the ICM 2018 criteria for PJI.MethodsThis is a retrospective study of patients who underwent revision total hip and total knee arthroplasty at a single institution between March 2009 and December 2019. All patients underwent joint aspiration before the arthrotomy, and the LE strip test was performed on aspirated joint fluid. PJI was defined using the 2018 ICM criteria.ResultsAs per the 2018 ICM criteria, 78 patients were diagnosed with chronic PJI and 181 were not infected. An LE test with a cutoff of 1+ had a sensitivity of 0.744, a specificity of 0.906, a positive predictive value of 0.773, an accuracy of 0.825 (95% confidence interval 0.772-0.878), and a negative predictive value of 0.891. The positive likelihood ratio (LR+) was 7.917. Using an LE cutoff of 2 + had a sensitivity of 0.513, a specificity of 1.000, and an accuracy of 0.756 (95% confidence interval—0.812).ConclusionLE is a rapid and inexpensive test which can be performed at the bedside. Its performance is valuable as per ICM criteria. Based on the findings of this study and the given cohort, we suggest using the cutoff of LE1+ (result = negative or trace) as a point of care test to exclude infection, whereas LE at 2 + threshold has near absolute specificity for the diagnosis. 相似文献
60.